Canada Life’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.52M | Buy |
68,585
+2,382
| +4% | +$151K | 0.01% | 790 |
|
|
2025
Q4 | $4.21M | Sell |
66,203
-12,341
| -16% | -$768K | 0.01% | 817 |
|
|
2025
Q3 | $4.23M | Hold |
78,544
| – | – | 0.01% | 890 |
|
|
2025
Q2 | $2.6M | Buy |
78,544
+9,512
| +14% | +$331K | ﹤0.01% | 1088 |
|
|
2025
Q1 | $2.77M | Sell |
69,032
-7,428
| -10% | -$341K | ﹤0.01% | 1063 |
|
|
2024
Q4 | $3.59M | Sell |
76,460
-12,680
| -14% | -$659K | 0.01% | 1000 |
|
|
2024
Q3 | $4.71M | Buy |
89,140
+19,414
| +28% | +$1.08M | 0.01% | 903 |
|
|
2024
Q2 | $3.77M | Buy |
69,726
+15,720
| +29% | +$949K | 0.01% | 973 |
|
|
2024
Q1 | $3.78M | Sell |
54,006
-51,186
| -49% | -$3.96M | 0.01% | 946 |
|
|
2023
Q4 | $8.76M | Buy |
105,192
+5,213
| +5% | +$189K | 0.02% | 566 |
|
|
2023
Q3 | $2.94M | Buy |
99,979
+914
| +0.9% | +$30.4K | 0.01% | 991 |
|
|
2023
Q2 | $3.23M | Sell |
99,065
-4,647
| -4% | -$172K | 0.01% | 936 |
|
|
2023
Q1 | $3.65M | Sell |
103,712
-6,133
| -6% | -$250K | 0.01% | 913 |
|
|
2022
Q4 | $5.04M | Sell |
109,845
-60
| -0.1% | -$2.58K | 0.01% | 730 |
|
|
2022
Q3 | $5.32M | Buy |
109,905
+25,978
| +31% | +$1.25M | 0.02% | 655 |
|
|
2022
Q2 | $3.3M | Buy |
83,927
+11,744
| +16% | +$473K | 0.01% | 878 |
|
|
2022
Q1 | $2.73M | Buy |
72,183
+863
| +1% | +$30.7K | 0.01% | 1044 |
|
|
2021
Q4 | $3.25M | Buy |
71,320
+1,151
| +2% | +$44.4K | 0.01% | 937 |
|
|
2021
Q3 | $2.53M | Buy |
70,169
+10,133
| +17% | +$298K | 0.01% | 1035 |
|
|
2021
Q2 | $1.19M | Sell |
60,036
-1,031
| -2% | -$24.2K | ﹤0.01% | 1439 |
|
|
2021
Q1 | $1.42M | Sell |
61,067
-6,704
| -10% | -$143K | ﹤0.01% | 1340 |
|
|
2020
Q4 | $1.41M | Sell |
67,771
-9,122
| -12% | -$167K | ﹤0.01% | 1335 |
|
|
2020
Q3 | $1.66M | Buy |
76,893
+3,697
| +5% | +$86.5K | ﹤0.01% | 1162 |
|
|
2020
Q2 | $1.72M | Sell |
73,196
-4,390
| -6% | -$82.3K | ﹤0.01% | 1158 |
|
|
2020
Q1 | $915K | Buy |
77,586
+5,056
| +7% | +$64.5K | ﹤0.01% | 1335 |
|
|
2019
Q4 | $761K | Buy |
+72,530
| New | +$745K | ﹤0.01% | 1598 |
|
|
2019
Q3 | – | Sell |
-77,085
| Closed | -$867K | – | 1412 |
|
|
2019
Q2 | $867K | Buy |
77,085
+10,482
| +16% | +$101K | ﹤0.01% | 1606 |
|
|
2019
Q1 | $538K | Hold |
66,603
| – | – | ﹤0.01% | 1607 |
|
|
2018
Q4 | $388K | Hold |
66,603
| – | – | ﹤0.01% | 1758 |
|
|
2018
Q3 | $652K | Hold |
66,603
| – | – | ﹤0.01% | 1672 |
|
|
2018
Q2 | $546K | Hold |
66,603
| – | – | ﹤0.01% | 1715 |
|
|
2018
Q1 | $477K | Hold |
66,603
| – | – | ﹤0.01% | 1746 |
|
|
2017
Q4 | $540K | Hold |
66,603
| – | – | ﹤0.01% | 1710 |
|
|
2017
Q3 | $959K | Sell |
66,603
-97
| -0.1% | -$1.32K | ﹤0.01% | 1530 |
|
|
2017
Q2 | $804K | Buy |
+66,700
| New | +$927K | ﹤0.01% | 1584 |
|
Other funds holding CYTK
VPM
VCM
ACA
Canada Life's CYTK Position: Q1 2026 in Review
Canada Life increased its Cytokinetics (CYTK) stake by 3.6% in Q1 2026, buying an estimated $151K and bringing the position to 68,585 shares worth $4.52M. The position accounts for 0.01% of the portfolio, ranked #790.
Canada Life first reported a position in CYTK in Q2 2017 and has held it in 35 quarters since. The position peaked at $8.76M in Q4 2023. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.
- Canada Life held 68,585 shares of Cytokinetics worth $4.52M as of Q1 2026.
- Canada Life bought 2,382 Cytokinetics shares in Q1 2026, an estimated $151K.
- Cytokinetics made up 0.01% of Canada Life's portfolio in Q1 2026, its #790 holding.
- Canada Life first reported a position in Cytokinetics in Q2 2017 and has held it in 35 quarters since.
- Canada Life's Cytokinetics position peaked at $8.76M in Q4 2023.
- 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.